An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease
Clinical trial NCT06497491 · COMPLETED
Trial details
- NCT number
- NCT06497491
- Sponsor
- AO GENERIUM
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-12
- Primary completion
- 2025-05-29
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.